Ringgold doctor sued under false claims act for administering unneeded drug
In a false claims suit filed against Dr.
In a 71-page complaint filed in
"Since at least 2012, (Burkich an his colleagues) have knowingly presented claims to
The
Chelatin therapy is performed by administering the drug EDTA that binds to metallic particles or ions in the body and causes them to be excreted with urine. The EDTA drug is FDA-approved only for treating lead poisoning, but the lawsuit claims "the vast majority of practitioners who administer intravenous chelation in their offices are using it to purportedly treat cardiovascular disease, which Medicare will not pay. To get payment for the services, "chelationists "must use creative coding that attempts to disguise what they do," the suit claims.
Public health officials reported that in 2012 and 2013 there were no reported blood tests showing lead poisoning among patients 65 and older in the counties served by
The complaints were filed after an investigation by the Inspector General of Investigations in the region, Thomas W. South.
"We will not allow greed to impede beneficiaries' access to necessary, quality health services,"
No one returned calls Tuesday from the
The false claims lawsuit against Burkich is not the first time the medical doctor has been in trouble with the law. In 2001, a Grand Jury in
He had to perform 150 hours of community service and pay a
Burkich lost his
Contact
___
(c)2019 the Chattanooga Times/Free Press (Chattanooga, Tenn.)
Visit the Chattanooga Times/Free Press (Chattanooga, Tenn.) at www.timesfreepress.com
Distributed by Tribune Content Agency, LLC.


Trump opponents turn up heat as NH rally nears
Insurance Agent Accused Of Scamming Elderly Arrested In NC
Advisor News
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
- The inheritance gap: Helping clients plan for money that hasn’t arrived
- After the midterms: Addressing your clients’ tax concerns
- Berkeley arts tax heads toward passage while public bank measure looks likely to fail
More Advisor NewsAnnuity News
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
- Annuities to play a larger role in workplace retirement plans
- FHLBank Pittsburgh Announces Results in 2026 Board Election
- Regulators advance shorter, streamlined annuity buyers guide
More Annuity NewsHealth/Employee Benefits News
- High costs limit rural Nebraskans’ access to health care
- Medicare is already reading your 2026 tax return
- LUJAN, WARNOCK LEAD BROAD COALITION OF SENATORS TO PUSH SENATE LEADERSHIP TO DELAY REPUBLICAN MEDICAID CUTS OVER CONCERNS ABOUT COVERAGE LOSS
- WARNOCK LEADS BROAD COALITION OF SENATORS TO PUSH SENATE LEADERSHIP TO DELAY REPUBLICAN MEDICAID CUTS OVER CONCERNS ABOUT COVERAGE LOSS
- What happens when Medicare coverage begins
More Health/Employee Benefits NewsLife Insurance News
- Military Briefs: November 12-18
- Security Benefit Series B Preferred Stock Dividend Rate Resets to 10.286%
- FHLBank Pittsburgh Announces Results in 2026 Board Election
- New Jackson Study Finds the "Sandwich Generation" Squeeze Comes from More Than Two Sides and It’s Quietly Draining Retirement Savings
- Samsung Fire & Marine Insurance to Acquire Outstanding Stake in Canopius with KKR and KIC
More Life Insurance News